ARQT logo

Arcutis Biotherapeutics, Inc. (ARQT) Selling, General & Administrative Expenses

Annual SG&A:

$229.39M+$44.25M(+23.90%)
December 31, 2024

Summary

  • As of today, ARQT annual SG&A is $229.39 million, with the most recent change of +$44.25 million (+23.90%) on December 31, 2024.
  • During the last 3 years, ARQT annual SG&A has risen by +$168.42 million (+276.23%).
  • ARQT annual SG&A is now at all-time high.

Performance

ARQT SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

Quarterly SG&A:

$0.00-$64.00M(-100.00%)
June 30, 2025

Summary

  • As of today, ARQT quarterly SG&A is $0.00, with the most recent change of -$64.00 million (-100.00%) on June 30, 2025.
  • Over the past year, ARQT quarterly SG&A has dropped by -$58.17 million (-100.00%).
  • ARQT quarterly SG&A is now -100.00% below its all-time high of $64.00 million, reached on March 31, 2025.

Performance

ARQT Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

TTM SG&A:

-$4.54B-$93.27M(-2.10%)
June 30, 2025

Summary

  • As of today, ARQT TTM SG&A is -$4.54 billion, with the most recent change of -$93.27 million (-2.10%) on June 30, 2025.
  • Over the past year, ARQT TTM SG&A has dropped by -$4.75 billion (-2271.23%).
  • ARQT TTM SG&A is now -18613.91% below its all-time high of -$24.28 million.

Performance

ARQT TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

ARQT Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+23.9%-100.0%-2271.2%
3Y3 Years+276.2%-100.0%-5455.4%
5Y5 Years+3370.4%-100.0%-10000.0%

ARQT Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+276.2%-100.0%at low-119.6%at low
5Y5-Yearat high+3370.4%-100.0%at low-891.6%at low
All-TimeAll-Timeat high>+9999.0%-100.0%at low>-9999.0%at low

ARQT Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$122.82M(-32.1%)
Mar 2025
-
$64.00M(>+9900.0%)
$180.99M(+5.4%)
Dec 2024
$229.39M(+23.9%)
$0.00(-100.0%)
$171.78M(-22.1%)
Sep 2024
-
$58.82M(+1.1%)
$220.46M(+5.4%)
Jun 2024
-
$58.17M(+6.2%)
$209.24M(+6.2%)
Mar 2024
-
$54.79M(+12.6%)
$197.02M(+6.4%)
Dec 2023
$185.15M(+51.6%)
$48.67M(+2.3%)
$185.15M(+6.7%)
Sep 2023
-
$47.59M(+3.6%)
$173.49M(+7.5%)
Jun 2023
-
$45.96M(+7.1%)
$161.37M(+12.8%)
Mar 2023
-
$42.92M(+15.9%)
$143.04M(+17.1%)
Dec 2022
$122.12M(+100.3%)
$37.02M(+4.4%)
$122.12M(+17.6%)
Sep 2022
-
$35.47M(+28.4%)
$103.83M(+22.4%)
Jun 2022
-
$27.62M(+25.5%)
$84.83M(+23.8%)
Mar 2022
-
$22.01M(+17.5%)
$68.52M(+12.4%)
DateAnnualQuarterlyTTM
Dec 2021
$60.97M(+185.8%)
$18.73M(+13.7%)
$60.97M(+24.6%)
Sep 2021
-
$16.47M(+45.6%)
$48.93M(+28.7%)
Jun 2021
-
$11.31M(-21.7%)
$38.02M(+17.6%)
Mar 2021
-
$14.45M(+116.1%)
$32.32M(+51.5%)
Dec 2020
$21.34M(+222.8%)
$6.69M(+20.3%)
$21.34M(+26.4%)
Sep 2020
-
$5.56M(-1.0%)
$16.88M(+23.9%)
Jun 2020
-
$5.62M(+61.9%)
$13.62M(+46.0%)
Mar 2020
-
$3.47M(+55.1%)
$9.33M(+41.1%)
Dec 2019
$6.61M(+268.2%)
$2.24M(-2.7%)
$6.61M(+32.8%)
Sep 2019
-
$2.30M(+73.7%)
$4.98M(+51.2%)
Jun 2019
-
$1.32M(+76.8%)
$3.29M(+67.2%)
Mar 2019
-
$749.00K(+23.6%)
$1.97M(+61.4%)
Dec 2018
$1.79M(+158.3%)
$606.00K(-1.3%)
$1.22M(+98.7%)
Sep 2018
-
$614.00K
$614.00K
Dec 2017
$695.00K
-
-

FAQ

  • What is Arcutis Biotherapeutics, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. annual SG&A year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. quarterly SG&A year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. TTM SG&A year-on-year change?

What is Arcutis Biotherapeutics, Inc. annual SG&A?

The current annual SG&A of ARQT is $229.39M

What is the all-time high annual SG&A for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high annual SG&A is $229.39M

What is Arcutis Biotherapeutics, Inc. annual SG&A year-on-year change?

Over the past year, ARQT annual SG&A has changed by +$44.25M (+23.90%)

What is Arcutis Biotherapeutics, Inc. quarterly SG&A?

The current quarterly SG&A of ARQT is $0.00

What is the all-time high quarterly SG&A for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high quarterly SG&A is $64.00M

What is Arcutis Biotherapeutics, Inc. quarterly SG&A year-on-year change?

Over the past year, ARQT quarterly SG&A has changed by -$58.17M (-100.00%)

What is Arcutis Biotherapeutics, Inc. TTM SG&A?

The current TTM SG&A of ARQT is -$4.54B

What is the all-time high TTM SG&A for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high TTM SG&A is -$24.28M

What is Arcutis Biotherapeutics, Inc. TTM SG&A year-on-year change?

Over the past year, ARQT TTM SG&A has changed by -$4.75B (-2271.23%)
On this page